NCT00684580

Brief Summary

Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for childhood cancer at St. Jude Children's Research Hospital.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30,000

participants targeted

Target at P75+ for all trials

Timeline
232mo left

Started Jun 2000

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Jun 2000May 2045

Study Start

First participant enrolled

June 8, 2000

Completed
8 years until next milestone

First Submitted

Initial submission to the registry

May 22, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 26, 2008

Completed
37 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2045

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2045

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

44.9 years

First QC Date

May 22, 2008

Last Update Submit

April 23, 2026

Conditions

Keywords

St. Jude AlumniSt. Jude Life Participants

Outcome Measures

Primary Outcomes (1)

  • To provide continuing review of outcome and late toxicity for all patients actively being followed or treated for childhood cancer at St. Jude Children's Research Hospital, all St Jude Alumni and all St. Life participants.

    25 years

Study Arms (1)

Observational Group

Data Collection

Other: Data Collection

Interventions

Continuing review of outcomes and late toxicities

Observational Group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients actively being treated and previously treated at St. Jude Children's Research Hospital for childhood cancer.

You may qualify if:

  • All St Jude patients actively being followed or treated for childhood cancer

You may not qualify if:

  • St. Jude consult only patients
  • St. Jude patients permanently discharged from care and follow-up Permanently discharged patients include patients who have electively transferred their oncologic care to another institution, those who are noncompliant with recommended follow-up or those leaving the institution against medical advice.
  • Patients referred to St. Jude for limited care on phase 1 protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Neoplasms

Interventions

Data Collection

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Melissa M Hudson, MD

    St. Jude Children's Research Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Melissa M Hudson, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2008

First Posted

May 26, 2008

Study Start

June 8, 2000

Primary Completion (Estimated)

May 1, 2045

Study Completion (Estimated)

May 1, 2045

Last Updated

April 29, 2026

Record last verified: 2026-04

Locations